| [1] |
Smyth RM, Spark P, Armstrong N，et al. Magpie trial in the UK: methods and additional data for women and children at 2 years following pregnancy complicated by pre-eclampsia. BMC Pregnancy Childbirth, 2009, 9：15.
|
| [2] |
Thangaratinam S, Coomarasamy A, Sharp S, et al. Tests for predicting complications of pre -eclampsia：a protocol for systematic reviews. BMC Pregnancy Childbirth, 2008, 8：38.
|
| [3] |
Kocyigit Y, Atamer Y, Atamer A, et al. Changes in serum levels of leptin, cytokines and lipoprotein in pre-eclamptic an normotensive pregnant women. Gynecol Endocrinol, 2004, 19(5): 267-273.
|
| [4] |
Cunninghan FG, Leveno KJ, Bloom SL, et al. Hypertensive disorder in pregnancy. In: Williams Obstetrics. 22nd ed. New York: McGraw-Hill, 2005：761-808.
|
| [5] |
Granger JP, Abram S, Stec D, et al. Endothelin, the kidney, and hypertension. Curr Hypertens Rep, 2006, 8(4): 298-303.
|
| [6] |
Zhao S, Gu Y, Coates G, et al. Altered nephrin and podoplanin distribution is associated with disturbed polarity protein PARD-3 and PARD-6 expressions in podocytes from preeclampsia. Reprod Sci, 2011, 18(8)：772-780.
|
| [7] |
李桦，马玉燕，牟瑞丽，等. 血管紧张素转化酶基因和血管紧张素II受体1基因多态性与子痫前期患者蛋白尿的相关性研究. 中华妇产科杂志，2006, 41(4)：264-265.
|
| [8] |
乐杰. 妇产科学. 7版. 北京：人民卫生出版社，2008：93-96.
|
| [9] |
Xiong X, Mayes D, Demianczuk N, et al. Impact of pregnancy induced hypertension on fetal growth. Am J Obstet Gynecol, 1999, 180(1)：207-213.
|
| [10] |
Urbschat A, Obermüller N, Haferkamp A. Biomarkers of kidney injury. Biomarkers, 2011, 16 Suppl 1: S22-S30.
|
| [11] |
Czekalski S. Diabetic nephropathy and cardiovascular diseases. Rocz Akad MedBialymst, 2005, 50: 122-125.
|
| [12] |
Yoshida H. Clinicopathological study of chronic kidney diseases (CKD). Rinsho byori, 2012, 60(2)：145-156.
|
| [13] |
Weinert LS, Camargo EG, Soares AA, et al. Glomerular filtration rate estimation: performance of serum cystatin C-based prediction equations. Clin Chem Lab Med, 2011, 49(11)：1761-1771.
|
| [14] |
Fligny C, Barton M, Tharaux PL. Endothelin and podocyte injury in chronic kidney disease. Contrib Nephrol, 2011, 172: 120-138.
|
| [15] |
Inker LA, Okparavero A. Cystatin C as a marker of glomerular filtration rate: prospects and limitations. Curr Opin Nephrol Hypertens, 2011, 20(6): 631-639.
|
| [16] |
Larciprete G, Liumbruno GM, Rongioletti M, et al. Thrombophilia and damage of kidney during pregnancy. Journal of Prenatal Medicine, 2011, 5(4)：78-82.
|
| [17] |
杨孜，李蓉，石凌懿，等. 早发型重度先兆子痫的临床界定及保守治疗探计．中华妇产科杂志，2005, 40(5)：302-305.
|
| [18] |
罗方媛，刘兴会，陈锰. 子痫前期孕妇血容量扩增受限与治疗. 中国实用妇科与产科杂志，2012, 28(8)：638-640.
|
| [19] |
林建华，乐怡平. 妊娠期高血压疾病低蛋白血症的诊治. 中国实用妇科与产科杂志，2012, 28(4)：256-258.
|